Cargando…
Ability of PITX2 methylation to predict survival in patients with prostate cancer
BACKGROUND: The aim of this study was to explore whether candidate gene methylation can effectively predict death from prostate cancer. METHODS: After reviewing the literature to identify likely candidate genes, we assembled a case-control cohort (in a 1:2 ratio) to explore the distribution of PITX2...
Autores principales: | Li, Jiu-zhi, Zhang, Yu, Wen, Bin, Li, Ming, Wang, Yu-jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4664542/ https://www.ncbi.nlm.nih.gov/pubmed/26648742 http://dx.doi.org/10.2147/OTT.S83914 |
Ejemplares similares
-
PITX2 methylation: a novel and effective biomarker for monitoring biochemical recurrence risk of prostate cancer
por: Jiang, Qi, et al.
Publicado: (2019) -
PITX2 and PANCR DNA methylation predicts overall survival in patients with head and neck squamous cell carcinoma
por: Sailer, Verena, et al.
Publicado: (2016) -
PITX3 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients after radical prostatectomy
por: Holmes, Emily Eva, et al.
Publicado: (2016) -
DNA Methylation of PITX2 and PANCR Is Prognostic for Overall Survival in Patients with Resected Adenocarcinomas of the Biliary Tract
por: Uhl, Barbara, et al.
Publicado: (2016) -
PITX2 DNA-methylation predicts response to anthracycline-based adjuvant chemotherapy in triple-negative breast cancer patients
por: Absmaier, Magdalena, et al.
Publicado: (2018)